Organigram Global (OGI) Non-Current Debt (2018 - 2024)
Organigram Global (OGI) posted quarterly Non-Current Debt of $18326.3 for Q3 2024, down 68.9% year-on-year from $58928.5 in Q4 2023, and down 68.9% on a QoQ basis from $58928.5 in Q3 2023.
Organigram Global (OGI) Non-Current Debt (2018 - 2024) Analysis & Trends
Organigram Global (OGI) has reported Non-Current Debt for 7 consecutive years, with $18326.3 the latest figure, recorded in Q3 2024.
- Quarterly Non-Current Debt fell 68.9% year-over-year to $18326.3 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $18326.3 (down 68.9% YoY) and the FY2024 annual result came in at $18326.3, down 68.72% from the prior year.
- Non-Current Debt retreated to $18326.3 in Q3 2024 per OGI's latest filing, from $58928.5 in the prior quarter.
- Over the last five years, Non-Current Debt for OGI reached as high as $77.1 million in Q3 2020 and fell as low as $18326.3 in Q3 2024.
- A 5-year average of $22.3 million and a median of $295000.0 in 2020 frame the typical range for Non-Current Debt.
- The largest YoY upside for Non-Current Debt was 17784.41% in 2021 against a maximum downside of 99.7% in 2021.
- Year by year, Non-Current Debt stood at $54.2 million in 2020, then tumbled by 99.61% to $211000.0 in 2021, then surged by 1783.88% to $4.0 million in 2022, then sank by 98.52% to $58928.5 in 2023, then slumped by 68.9% to $18326.3 in 2024.
- According to Business Quant data, Non-Current Debt over the past three periods registered $18326.3, $58928.5, and $4.0 million for Q3 2024, Q3 2023, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18,326.34 |
| Sep 30, 2023 | 58,928.51 |
| Aug 31, 2022 | 3.97 Mn |
| Nov 30, 2021 | 211,000.00 |
| Aug 31, 2021 | 230,000.00 |
| May 31, 2021 | 247,000.00 |
| Feb 28, 2021 | 52.76 Mn |
| Nov 30, 2020 | 54.17 Mn |
| Aug 31, 2020 | 77.15 Mn |
| May 31, 2020 | 56.41 Mn |
| Feb 29, 2020 | 295,000.00 |
| Aug 31, 2019 | 34.84 Mn |
| May 31, 2019 | 47.20 Mn |
| Aug 31, 2018 | 2.20 Mn |